YH-44529

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameYH-44529
Drug Alias NameKNP-504CYRS-1645YH44529YH-44529
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKanaph Therapeutics IncCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKanaph Therapeutics IncCyrus Therapeutics IncYuhan Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A